KCNA3 and chronic obstructive pulmonary disease: Compared with those caused by sulphonylureas, the side effects of hypoglycaemia and weight gain caused by meglitinide are relatively mild.12 This may also affect patients with COPD because of the inhibition of the potassium channels.